A detailed history of Sage Rhino Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sage Rhino Capital LLC holds 6,881 shares of JNJ stock, worth $1.05 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
6,881
Previous 6,988 1.53%
Holding current value
$1.05 Million
Previous $1.02 Million 9.21%
% of portfolio
0.25%
Previous 0.25%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$145.48 - $167.38 $15,566 - $17,909
-107 Reduced 1.53%
6,881 $1.12 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $6,785 - $7,415
-47 Reduced 0.67%
6,988 $1.02 Million
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $14,745 - $15,460
95 Added 1.37%
7,035 $1.11 Million
Q4 2023

Feb 05, 2024

SELL
$145.6 - $158.88 $3,348 - $3,654
-23 Reduced 0.33%
6,940 $1.09 Million
Q3 2023

Oct 26, 2023

SELL
$155.75 - $174.48 $4,205 - $4,710
-27 Reduced 0.39%
6,963 $1.08 Million
Q2 2023

Jul 31, 2023

BUY
$154.35 - $166.11 $2,006 - $2,159
13 Added 0.19%
6,990 $1.16 Million
Q1 2023

Apr 20, 2023

SELL
$151.05 - $180.26 $33,079 - $39,476
-219 Reduced 3.04%
6,977 $1.08 Million
Q4 2022

Jan 31, 2023

BUY
$160.2 - $179.79 $7,369 - $8,270
46 Added 0.64%
7,196 $1.27 Million
Q3 2022

Oct 24, 2022

SELL
$161.33 - $179.52 $13,713 - $15,259
-85 Reduced 1.17%
7,150 $1.17 Million
Q2 2022

Jul 28, 2022

BUY
$168.19 - $186.01 $6,054 - $6,696
36 Added 0.5%
7,235 $1.28 Million
Q1 2022

Apr 27, 2022

BUY
$158.14 - $179.59 $2,530 - $2,873
16 Added 0.22%
7,199 $1.28 Million
Q4 2021

Feb 04, 2022

BUY
$155.93 - $173.01 $24,169 - $26,816
155 Added 2.21%
7,183 $1.23 Million
Q3 2021

Oct 18, 2021

BUY
$161.5 - $179.47 $2,584 - $2,871
16 Added 0.23%
7,028 $1.14 Million
Q2 2021

Jul 27, 2021

BUY
$159.48 - $171.07 $16,107 - $17,278
101 Added 1.46%
7,012 $1.16 Million
Q1 2021

May 04, 2021

BUY
$153.07 - $170.48 $33,063 - $36,823
216 Added 3.23%
6,911 $1.14 Million
Q4 2020

Feb 03, 2021

BUY
$137.11 - $157.38 $9,871 - $11,331
72 Added 1.09%
6,695 $1.05 Million
Q3 2020

Nov 05, 2020

BUY
$140.38 - $153.83 $561 - $615
4 Added 0.06%
6,623 $986,000
Q2 2020

Jul 30, 2020

BUY
$128.81 - $155.51 $17,904 - $21,615
139 Added 2.15%
6,619 $931,000
Q1 2020

Apr 29, 2020

BUY
$111.14 - $153.99 $13,447 - $18,632
121 Added 1.9%
6,480 $850,000
Q4 2019

Jan 31, 2020

BUY
$127.5 - $146.44 $6,757 - $7,761
53 Added 0.84%
6,359 $922,000
Q3 2019

Oct 25, 2019

BUY
$126.95 - $142.14 $507 - $568
4 Added 0.06%
6,306 $816,000
Q2 2019

Aug 20, 2019

BUY
$131.15 - $144.24 $9,705 - $10,673
74 Added 1.19%
6,302 $878,000
Q1 2019

Apr 18, 2019

BUY
$125.72 - $139.79 $782,984 - $870,612
6,228 New
6,228 $871,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.